- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03417219
Mobile Tablet Education to Advance Caregiver Health (MTEACHing)
Mobile Media Intervention for Family Caregivers of Veterans With Dementia
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The proposed project studies the effects of an education and skill-building rehabilitation intervention, designed to be low-cost and clinically translatable through mobile media devices (i.e., tablets), on family caregivers of Veterans with dementia. Intervention effects will be examined longitudinally at baseline and 3 months post-intervention.
Advanced statistical techniques will be used to determine the impact of the intervention on: quality of life in caregivers of Veterans with dementia (Aim 1), perceived stress and depressive symptoms in caregivers (Aim 2), and socialization and engagement in pleasant activities in caregivers (Aim 3).
If this rehabilitative intervention proves successful, it may represent an approach to Veteran- and family-centered dementia care that can be used throughout VA with low staff, resource, and cost burdens.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
California
-
Palo Alto, California, Forenede Stater, 94304-1290
- VA Palo Alto Health Care System, Palo Alto, CA
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-- Participants must:
- report distress associated with being the primary caregiver for a family member with dementia
- reporting at least 2 of the following 6 items at baseline assessment: felt overwhelmed, felt like they often needed to cry, were angry or frustrated, felt they were cut off from family or friends, reported moderate to high levels of general stress, or felt their health had declined
- provide at least 7 hours of care (supervision or direct assistance) per week over the past 3 months (other sources of caregiving for the Veteran with dementia can also be utilized; e.g., respite, home health aide, other family members)
- cohabitate with a Veteran diagnosed with dementia
- be proficient in spoken and written English
- be capable of providing informed consent
Exclusion Criteria:
-- Potential participants will be screened and excluded for:
- current or lifetime history of any psychiatric disorder with psychotic features
- prominent suicidal or homicidal ideation
- having met DSM-IV criteria for drug or alcohol abuse or dependence (except nicotine) within the past six months
- presence of alcohol intoxication (by breathalyzer) or alcohol withdrawal (by exam) during study recruitment or participation
- diagnosis of probable or possible dementia
- a Telephone Cognitive Screen score of < 20
- participation in another caregiver intervention study within the past year
- lack of access to telephone and internet services in the home
- illness that would prevent study participation
- planned transfer of care receiver to another caregiver or nursing home within 6 months
- currently living with an implantable cardioverter defibrillator or pacemaker
- known pregnancy at time of consent
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Mobile Media Education and Skill-Building Rehabilitation Int
The investigators' ESBR-m intervention consists of four, 90-minute group (= 5 participants) sessions.
These four sessions are supplemented with a booster session one month following the last intervention session.
|
Participants randomized to the ESBR-m group will participate in four, 90-minute group ( 5 participants) sessions.
These four sessions are supplemented with a booster session one month following the last intervention session.
|
|
Aktiv komparator: Usual Care
Usual Care (plus supplemental educational materials).
Participants randomized to the Usual Care (UC) group will receive supplemental educational materials (e.g., VA Caregiver Support Program; Veterans Crisis Line; National Institute on Aging's "Understanding Memory Loss").
|
Participants randomized to the UC group will receive supplemental educational materials (e.g., VA Caregiver Support Program; Veterans Crisis Line; National Institute on Aging's "Understanding Memory Loss").
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change From Baseline Zarit Burden Interview (ZBI) at 4 Months
Tidsramme: Baseline, 4 month follow-up
|
The Zarit Burden Interview (ZBI) is a 22-item self-report measure of caregiver burden.
Several version of the ZBI have been used successfully as outcome measures in interventions for dementia caregivers.
Scores for each item range from 0 (never) to 4 (nearly always) on questions such as "Do you feel embarrassed by your relative's behavior?."
Total scores are calculated by summing all responses and range from 0-88.
A higher score is indicative of a worse outcome.
|
Baseline, 4 month follow-up
|
|
Change From Baseline Center for Epidemiological Studies-Depression (CES-D) at 4 Months
Tidsramme: Baseline, 4 month follow-up
|
The Center for Epidemiological Studies-Depression (CES-D) is a 20-item, self-report measure of frequency of depressive symptoms over a one week period.
The CES-D is frequently used to assess depression in dementia caregivers and has been shown to be sensitive to changes in caregiver depression post intervention.
Scores for each item range from 0 (rarely or none of the time) to 3 (most or all of the time), with some items reverse coded.
Total scores are calculated by summing all responses and range from 0-60.
A higher score is indicative of a worse outcome.
|
Baseline, 4 month follow-up
|
|
Change From Baseline Perceived Stress Scale (PSS) at 4 Months
Tidsramme: Baseline, 4 month follow-up
|
The Perceived Stress Scale (PSS) is the most widely used psychological instrument for measuring the perception of stress.
It is a measure of the degree to which situations in one's life are appraised as stressful.
Items were designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives.
The scale also includes a number of direct queries about current levels of experienced stress.
We use a 14 item version of the PSS with a minimum score of 0 and a maximum score of 56.
Lower values indicate lower perceived stress while higher values indicate higher perceived stress.
|
Baseline, 4 month follow-up
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Blake K Scanlon, PhD, VA Palo Alto Health Care System, Palo Alto, CA
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- E1710-P
- 1I21RX001710 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Demens
-
ACADIA Pharmaceuticals Inc.RekrutteringLewy Body Dementia PsychosisForenede Stater, Tjekkiet, Serbien, Frankrig, Bulgarien, Italien
-
ACADIA Pharmaceuticals Inc.Tilmelding efter invitationLewy Body Dementia PsychosisForenede Stater, Tjekkiet, Bulgarien